Kura Oncology Ratios (2024-2025) | KURA

Ratios Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
EBT Margin 12,443.47%12,521.43%13,204.85%4,267.74%-405.46%-432.51%-357.19%
EBIT Margin 13,681.41%13,892.61%14,534.95%5,571.96%-458.61%-475.31%-385.53%
EBITDA Margin 12,329.15%12,434.48%12,821.60%4,855.83%-458.61%-475.31%-385.53%
Operating Margin 13,681.41%13,892.61%14,534.95%5,571.96%-458.61%-475.31%-385.53%
Net Margin 12,443.47%12,521.43%13,204.85%4,267.74%-407.07%-432.51%-357.19%
FCF Margin 12,293.47%10,479.31%10,543.69%-66,689.58%-511.90%-197.77%-400.93%
Efficiency
Assets Average 534.51M496.98M619.50M751.96M713.09M665.90M
Equity Average 485.58M444.92M418.71M389.02M334.95M274.01M
Invested Capital 505.08M466.92M425.49M416.25M366.33M308.60M246.88M
Asset Utilization Ratio 0.000.020.040.07
Leverage & Solvency
Interest Coverage Ratio -136.81-138.93-145.35-55.72-169.37-185.85-203.55
Debt to Equity 0.020.020.020.020.030.030.04
Debt Ratio 0.020.020.020.010.010.010.01
Equity Ratio 0.910.900.890.540.490.450.37
Times Interest Earned -136.81-138.93-145.35-55.72-169.37-185.85-203.55
Valuation
Enterprise Value 1,096.88M1,077.04M1,042.14M-50.07M-125.21M-131.19M218.49M
Market Capitalization 1,624.00M1,568.56M1,497.44M677.32M532.98M499.54M768.16M
Return Ratios
Return on Sales 106.22%-13.96%-6.83%-4.32%
Return on Capital Employed -0.36%-0.31%-0.36%-0.44%
Return on Assets -0.28%-0.24%-0.27%-0.32%
Return on Equity -0.41%-0.46%-0.58%-0.78%